Antisense oligonucleotides intended to specifically reduce the progerin-expressing, aberrant splice form of LMNA have proven effective in a mouse model of HGPS, substantially increasing the lifespans of the mice (by 62% in one study)[2,3]. Here, LMNA is linked to Hutchinson-Gilford progeria syndrome.